Oncogene – celebrates 20 years of shaping the scientific community and publishing the latest developments in cancer research. Oncogene is published weekly and covers the structure and function of oncogenes. Oncogene publishes several review issues annually – Oncogene Reviews takes a closer look into the advances that are impacting the study of cancer.
Free online issue
Volume 27, No 56
27 November 2008
ISSN: 0950-9232
EISSN: 1476-5594
2007 impact factor 6.44*
14/132 Oncology
14/132 Genetics & Heredity
26/156 Cell Biology
32/263 Biochemistry & Molecular Biology
Editors:
J Jenkins
E P Reddy
* Journal Citation Reports, Thomson Reuters, 2008
FEATURED ARTICLES
ORIGINAL ARTICLE
RAN mediates OPN-induced invasionORIGINAL ARTICLE
Cell survival and repression of BIM by BRAFV600EORIGINAL ARTICLE
mGluR1 for melanoma growth in vivoORIGINAL ARTICLE
Reverse of 5-FU chemoresistance by targeting Src tyrosine kinaseORIGINAL ARTICLE
In vivo siRNA Id2 targeting in colon cancerORIGINAL ARTICLE
Hypoxia in maspin-expressing prostate tumorsOncogene News
Harmful BMP's. Bone morphogenetic protein (BMP) signaling make breast cancer patients more prone to bone metastasis. Read about Smad pathways role in cell signal causing greater skeletal deformities.
Submit your paper to Nature Precedings. while your manuscript is under consideration. This archive provides a rapid way to disseminate emerging results and new theories, solicit opinions, and record the provenance of ideas. Register to submit documents now.
Oncogene Reviews
PTEN's dynamic users guide. Mechanizing apoptosis is one of many possible future applications involving PTEN. The genes manipulative abilities help to chart out its true role in tumor suppression and genome stability. Read this special reviews issue that showcases PTEN branching involvement in the physiology, pharmacology and genetics of cancer.
Apoptosis reviews series. Read articles on FLIP, Bcl-2 and caspase-independent cell death in this special two-part reviews issue covering the intrinsic and extrinsic pathways of apoptosis.
Other NPG news
Gene therapy for prostate cancer. Prostate cancer affects one in six men and is the second leading cause of cancer death among men in the US. Gene therapy shows promise as a treatment strategy that can target both localized and metastatic prostate cancer. View this web focus to read more about the field of prostate cancer gene therapy.
-
Research and Reviews
Latest research highlights and reviews from the NPG family of journals
- The 'glutamate switch' provides a link between ATPase activity and ligand binding in AAA+ proteins - this content is FREE Source: Nature Structural and Molecular Biology
- Bacterial biofilms in patients with indwelling urinary catheters - this content is FREE Source: Nature Clinical Practice Urology
- Hepatitis C virus infection protein network - this content is FREE Source: Molecular Systems Biology

